Schedule Y Guidelines
Human pharmacology for biologicals – First into man studies Daren Austin PhD Clinical Pharmacology Discovery Medicine GlaxoSmithKline.
10.28.08(b): Antidepressant Medication
10.30.08(b): Antipsychotic Drugs
Farmacokinetics sab 2015
The NCI Approach To Drug Development Edward A. Sausville, M.D., Ph.D. Developmental Therapeutics Program National Cancer Institute.
Veterinary Compounding Skip Lenz, Pharm. D, F.A.C.V.P., F.A.S.C.P.
Biomarkers: Physiological & Laboratory Markers of Drug Effect Janet Woodcock, M.D. Deputy Commissioner and Chief Medical Officer Food and Drug Administration.
Relevance of pre-clinical findings for the interpretation of Adverse Events
